# Llanten (Plantago lanceolata)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/llanten-plantago-lanceolata
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Plantago lanceolata, Ribwort Plantain, Narrowleaf Plantain, Lanceleaf Plantain, Llantén

## Overview

Llanten contains iridoid glycosides (aucubin up to 4.8%, catalpol 1–2%) and phenylethanoid glycosides (acteoside up to 7.1%) that suppress inflammation by inhibiting lipoxygenases (acteoside IC₅₀ 96–117 μM), cyclooxygenases (ursolic acid IC₅₀ 130 μM on COX-2), and protein kinase C. Preclinical wound-healing and [anti-inflammatory](/ingredients/condition/inflammation) studies in rodent models support its traditional Quechua use for topical wound care, though no large-scale human clinical trials have quantified effect sizes in standardized populations.

## Health Benefits

- **Wound Healing**: Aucubin and acteoside promote tissue repair through [anti-inflammatory](/ingredients/condition/inflammation) enzyme inhibition and [immunomodulatory](/ingredients/condition/immune-support) polysaccharide activation; traditional Quechua use specifically targets topical wound closure and infection reduction.
- **Anti-Inflammatory Activity**: Acteoside inhibits 15-lipoxygenase (IC₅₀ 117 μM) and plantamajoside inhibits 15-LOX (IC₅₀ 96 μM), while ursolic acid suppresses COX-2 (IC₅₀ 130 μM), collectively dampening the arachidonic acid inflammatory cascade.
- **Antioxidant Protection**: Caffeic acid derivatives, luteolin 7-glucoside, and acteoside scavenge [reactive oxygen species](/ingredients/condition/antioxidant) and reduce oxidative stress in cell-based assays, contributing to tissue-protective effects.
- **Immunomodulation**: Polysaccharide fraction PMII activates monocytes to produce TNF-α and inhibits complement pathways, suggesting a dual immunostimulatory and anti-inflammatory regulatory role.
- **Antimicrobial and Antiviral Effects**: Flavonoids baicalein and scutellarein inhibit HIV reverse transcriptase (IC₅₀ 2.5–5.6 μM in vitro), and weak antibiotic activity against common pathogens has been demonstrated in preclinical screens.
- **Respiratory and Mucosal Support**: Traditional preparations as teas or decoctions are used for coughs and upper respiratory mucosa irritation, with mucilaginous polysaccharides providing demulcent coating and anti-inflammatory action on bronchial epithelia.
- **Antiulcerogenic Activity**: Preclinical rodent models suggest that phenolic-rich extracts reduce gastric mucosal damage, attributed to antioxidant and COX-inhibitory activity of ursolic acid and caffeic acid derivatives.

## Mechanism of Action

Acteoside and plantamajoside inhibit 15-lipoxygenase (IC₅₀ 117 μM and 96 μM, respectively), reducing leukotriene biosynthesis from arachidonic acid, while acteoside also binds the catalytic domain of protein kinase C to attenuate downstream pro-inflammatory signaling. Ursolic acid, concentrated in chloroform extracts at approximately 63% of triterpenic acid fraction, inhibits COX-2 (IC₅₀ 130 μM) more selectively than COX-1 (IC₅₀ 295 μM), diminishing [prostaglandin](/ingredients/condition/inflammation) E2 synthesis. The flavonoid hispidulin inhibits 5-lipoxygenase and suppresses LPS-induced nitric oxide production in macrophages, while baicalein inhibits 12-lipoxygenase and acts as a competitive HIV reverse transcriptase inhibitor. Polysaccharide PMII activates monocyte TNF-α production and modulates complement activation, providing immunoregulatory balance that supports wound resolution and pathogen defense.

## Clinical Summary

No controlled human clinical trials have been identified for Plantago lanceolata in wound healing, inflammation, or any other primary endpoint with reported sample sizes or effect sizes. Existing human-relevant data derives exclusively from in vitro cell-culture studies and rodent in vivo models, which demonstrate [anti-inflammatory](/ingredients/condition/inflammation) and wound-healing activity consistent with traditional Quechua applications. The absence of pharmacokinetic or bioavailability data in humans makes dose extrapolation from preclinical IC₅₀ values unreliable. Confidence in clinical efficacy remains low pending properly designed Phase I/II trials, and practitioners should regard current evidence as hypothesis-generating rather than confirmatory.

## Nutritional Profile

Plantago lanceolata leaves contain iridoid glycosides (aucubin 1.0–4.8%, catalpol 1–2% dry weight), phenylethanoid glycosides (acteoside 1.5–7.1%), and flavonoids including luteolin 7-glucoside, baicalein, hispidulin, and scutellarein. Fatty acid composition includes α-linolenic acid (18:3ω-3) at approximately 33.3% and linoleic acid (18:2ω-6) at 11.2% of total fatty acids, making it a moderate source of omega-3 precursors relative to its small leaf mass consumed. Polysaccharides (notably PMII with branched arabinogalactan-type side chains) and triterpenic acids (ursolic acid as major component) contribute to [immunomodulatory](/ingredients/condition/immune-support) and [anti-inflammatory](/ingredients/condition/inflammation) properties. Caffeic acid, fumaric acid, and chlorogenic acid derivatives provide additional [antioxidant](/ingredients/condition/antioxidant) capacity; bioavailability of these phenolics is influenced by extraction method, with ethanol outperforming water for phenolics and water superior for polysaccharides.

## Dosage & Preparation

- **Traditional Leaf Tea (Infusion)**: Dried or fresh leaves steeped in 150–250 mL boiling water for 10–15 minutes; consumed 2–3 times daily for respiratory or digestive complaints in folk traditions; no standardized dose established.
- **Aqueous Extract (Polysaccharide-Rich)**: Prepared at 100°C to maximize PMII polysaccharide yield; used in preclinical [immunomodulat](/ingredients/condition/immune-support)ion studies; no human dose defined.
- **Ethanol Extract (Phenolic-Rich)**: 50–70% ethanol extractions concentrate acteoside and caffeic acid derivatives; standardization to acteoside content (target 1.5–7.1% by dry weight) has been proposed in phytochemical literature but not adopted in clinical guidelines.
- **Chloroform Extract (Triterpenoid-Rich)**: Concentrates ursolic acid and other triterpenic acids (~63% of extract); used in preclinical COX-inhibition assays; not a standard consumer preparation form.
- **Topical Poultice**: Fresh leaf applied directly to wounds or skin irritations per Quechua traditional practice; duration and frequency unspecified in clinical literature.
- **Standardization Note**: Aucubin and acteoside concentrations vary significantly by cultivar (Grasslands Lancelot vs. Ceres Tonic) and harvest season (spring to mid-fall); mid-fall harvest yields highest bioactive concentrations.

## Safety & Drug Interactions

Plantago lanceolata is generally regarded as well-tolerated at doses used in traditional herbal preparations, but formal human safety studies establishing maximum tolerated doses, NOAEL values, or adverse event profiles are absent from the published literature. Allergic contact dermatitis has been reported anecdotally in individuals sensitized to Plantaginaceae, and patients with grass pollen allergies may experience cross-reactivity. No systematically studied drug interactions have been identified; however, given its mild COX and LOX inhibitory activity, theoretical additive effects with NSAIDs, anticoagulants, or immunosuppressants cannot be excluded and warrant caution. Pregnancy and lactation safety has not been evaluated in controlled studies, and use during these periods should follow conservative guidance limiting intake to culinary quantities until further data are available.

## Scientific Research

The evidence base for Plantago lanceolata is currently restricted to in vitro biochemical assays and in vivo rodent models; no peer-reviewed human clinical trials with defined sample sizes, randomization, or quantified effect sizes have been published specifically for llanten in wound healing or [anti-inflammatory](/ingredients/condition/inflammation) endpoints. Preclinical studies have characterized enzyme inhibition kinetics (IC₅₀ values for LOX and COX isoforms) and demonstrated wound-healing activity in rat excision models, providing mechanistic plausibility but limited translational certainty. Phytochemical studies have rigorously quantified seasonal and cultivar-dependent variation in aucubin (1.0–4.8% dry matter) and acteoside (1.5–7.1% dry matter), which is relevant for standardization but does not constitute clinical efficacy data. Overall, the scientific evidence is preliminary, consistent with a traditional-use herb that has received meaningful preclinical attention but lacks the clinical trial infrastructure required for regulatory health claims.

## Historical & Cultural Context

Plantago lanceolata has been documented in European herbal medicine since antiquity, referenced by Dioscorides and later by medieval herbalists for wound healing, [inflammation](/ingredients/condition/inflammation), and digestive complaints, reflecting a cross-cultural convergence of therapeutic application. In Andean South America, Quechua-speaking communities incorporated llanten into traditional medicine for topical wound care, attributing healing properties to what modern phytochemistry has identified as allantoin-related and polyphenolic constituents, though allantoin itself is more characteristic of Symphytum than Plantago. The plant's cosmopolitan naturalization, often called 'white man's footprint' by Indigenous North American communities due to its spread alongside European colonization, reflects both its ecological resilience and its rapid adoption into diverse indigenous pharmacopoeias. In European folk traditions, preparations ranged from fresh leaf poultices and water decoctions to expressed juice applied to wounds, closely paralleling Andean practices and suggesting independently validated ethnopharmacological utility.

## Synergistic Combinations

Llanten's acteoside and ursolic acid, targeting LOX and COX pathways respectively, may complement quercetin-rich herbs (e.g., elderflower or chamomile) that additionally inhibit NF-κB activation, providing broader anti-[inflammatory pathway](/ingredients/condition/inflammation) coverage than any single herb. Pairing polysaccharide-rich aqueous llanten extracts with beta-glucan sources such as oat or medicinal mushrooms (e.g., Ganoderma lucidum) may produce additive [immunomodulatory](/ingredients/condition/immune-support) effects via converging monocyte and macrophage activation mechanisms. For wound-healing applications, traditional combination with calendula (Calendula officinalis), which contributes triterpenoid saponins and additional flavonoids, mirrors ethnobotanical practice and offers mechanistically plausible synergy through complementary tissue-remodeling and antimicrobial activity.

## Frequently Asked Questions

### What is llanten used for in traditional medicine?

In Quechua and broader South American folk medicine, llanten (Plantago lanceolata) is used primarily for wound healing, skin inflammation, respiratory complaints such as coughs, and digestive ailments. Traditional preparations include fresh leaf poultices applied topically and water decoctions consumed as teas, with bioactive compounds aucubin, acteoside, and polysaccharides considered responsible for the anti-inflammatory and tissue-repair effects.

### What are the active compounds in Plantago lanceolata?

The principal bioactive compounds in Plantago lanceolata include iridoid glycosides (aucubin 1.0–4.8% and catalpol 1–2% of dry weight), phenylethanoid glycosides (acteoside 1.5–7.1%), triterpenic acids (ursolic acid), flavonoids (luteolin 7-glucoside, baicalein, hispidulin), immunomodulatory polysaccharides (PMII), and caffeic acid derivatives. Concentrations vary significantly by cultivar and harvest season, with mid-fall harvests yielding the highest levels of aucubin and acteoside.

### Is there scientific evidence that llanten works for wound healing?

Current evidence is limited to in vitro enzyme inhibition studies and rodent in vivo wound-healing models; no human clinical trials with defined sample sizes or effect sizes have been published. Preclinical data demonstrate that acteoside inhibits 15-lipoxygenase (IC₅₀ 117 μM) and ursolic acid inhibits COX-2 (IC₅₀ 130 μM), supporting mechanistic plausibility for anti-inflammatory wound-healing effects. The evidence is classified as preliminary, and clinical confirmation through randomized controlled trials is needed.

### How do you prepare llanten tea or extract at home?

A traditional llanten infusion is prepared by steeping 1–2 teaspoons of dried Plantago lanceolata leaves in 150–250 mL of boiling water for 10–15 minutes, then straining and consuming 2–3 cups daily. For topical use, fresh leaves can be cleaned and applied as a poultice directly to minor wounds or skin irritations, consistent with Quechua ethnobotanical practice. Ethanol-based tinctures (50–70% ethanol) extract higher concentrations of acteoside and phenolic compounds compared to water alone, but no clinically validated dosage protocol exists for any preparation form.

### Are there any side effects or drug interactions with llanten?

Plantago lanceolata is generally well-tolerated in traditional use quantities, but formal human safety data are lacking. Individuals with Plantaginaceae or grass pollen allergies may experience allergic reactions, including contact dermatitis. Due to its mild COX and lipoxygenase inhibitory activity, theoretical interactions with NSAIDs, anticoagulants, or immunosuppressant drugs are plausible, and caution is advised when combining llanten supplements with these medication classes until clinical interaction studies are conducted.

### What is the most effective form of llanten for wound healing—fresh leaf, dried herb, or extract?

Fresh leaf poultices and standardized extracts containing aucubin and acteoside are considered most effective for topical wound healing, as these forms concentrate the active compounds responsible for anti-inflammatory and tissue-repair activity. Dried herb infusions work well for internal anti-inflammatory support, though topical application directly to wounds has stronger traditional and emerging clinical validation. Extract forms allow for controlled dosing of bioactive glycosides, making them preferable for clinical or standardized protocols.

### Is llanten safe to use during pregnancy and breastfeeding?

While llanten has a long history of traditional use, there is limited clinical safety data specifically for pregnancy and breastfeeding populations, so it should be used with caution or avoided during these periods unless recommended by a healthcare provider. The herb's polysaccharide and iridoid glycoside content suggests potential uterine activity in some herbalism traditions, though this has not been definitively confirmed in human studies. Topical use on minor wounds is generally considered lower-risk than internal consumption during pregnancy.

### How does the anti-inflammatory potency of llanten compare to other traditional wound-healing herbs like comfrey or calendula?

Llanten's acteoside and plantamajoside inhibit 15-lipoxygenase with IC₅₀ values of 96–117 μM, providing measurable anti-inflammatory activity comparable to other herbal anti-inflammatories, though direct head-to-head studies with comfrey or calendula are limited. Unlike comfrey, which contains potentially hepatotoxic pyrrolizidine alkaloids, llanten lacks known hepatotoxic constituents, making it a safer choice for prolonged internal use. Calendula is stronger for acute inflammation, while llanten excels at promoting tissue repair and infection prevention through its immunomodulatory polysaccharides.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*